TrialAnnals of the rheumatic diseases2011

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.

Philip G Conaghan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.